Boehringer Ingelheim VC backs plan to send GMO bacteria after tumors
Chris Thanos wants to send bacteria after your tumors.
Specifically, he wants to send salmonella after your tumors, a genetically modified form of the microbe that he and his team have neutered and retrofitted with genetic warheads. It’s an attractive idea, at least to Boehringer Ingelheim Venture Fund and Panacea Venture, who today co-led a $34 million Series A round for Thanos’s Berkeley-based company, Actym Therapeutics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.